Physician profile
Omar Hasan
NPI 1558626564
$15,460.94
in general payments reported to CMS, 2019-2025
43 companies · $1,531 in 2025
The $1,531 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,067 · 2020: $5,634 · 2021: $1,133 · 2022: $1,506 · 2023: $1,089 · 2024: $1,501 · 2025: $1,531.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,926 · Education: $195.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,926.39 |
| Education | $194.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,484.17 | 2019-2022 | |
| Glaxosmithkline, LLC. | $1,725.07 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $1,535.55 | 2019-2025 | Fasenra, Airsupra, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,144.46 | 2019-2025 | Ofev, Stiolto Respimat, Jascayd |
| Genzyme Corporation | $858.60 | 2020-2025 | |
| Regeneron Healthcare Solutions, INC. | $644.06 | 2019-2025 | Dupixent |
| Grifols USA, LLC | $448.20 | 2019-2025 | Prolastin-C Liquid |
| Ethicon INC. | $433.03 | 2019 | |
| Insmed, INC. | $380.98 | 2019-2025 | Arikayce, Brinsupri |
| Takeda Pharmaceuticals U.S.A., INC. | $354.33 | 2020-2024 | Cuvitru, Glassia |
| Astellas Pharma US INC | $283.27 | 2019-2023 | Cresemba |
| Amgen INC. | $270.76 | 2019-2025 | Tezspire |
| Philips North America LLC | $204.91 | 2019-2023 | |
| Mylan Specialty L.P. | $181.73 | 2019-2024 | Yupelri |
| Merck Sharp & Dohme LLC | $144.48 | 2019-2025 | Zerbaxa, Recarbrio |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Omar Hasan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.